AIM
VSTM icon

Aigen Investment Management’s Verastem VSTM Stock Holding History

Aigen Investment Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,431
Closed -$119K – 1010
2025
Q3 		$119K Buy
+13,431
New +$100K 0.02% 725

Other funds holding VSTM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Aigen Investment Management's VSTM Position: Q4 2025 in Review

Aigen Investment Management sold out of Verastem (VSTM) in Q4 2025, closing a stake of 13,431 shares — an estimated $119K sold.

Aigen Investment Management first reported a position in VSTM in Q3 2025 and held it in 1 quarter. The position peaked at $119K in Q3 2025. 142 funds tracked by Wall St. Rank hold VSTM as of Q4 2025.

  • Aigen Investment Management reported no remaining Verastem position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 13,431 Verastem shares in Q4 2025, an estimated $119K.
  • Aigen Investment Management first reported a position in Verastem in Q3 2025 and held it in 1 quarter.
  • Aigen Investment Management's Verastem position peaked at $119K in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Verastem as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.